Global Stem Cell Therapy Market Report 2023: Featuring Anterogen, JCR Pharmaceuticals, Medipost, Osiris Therapeutics and Pharmicell Among Others

DUBLIN, March 20, 2023 /PRNewswire/ -- The "Stem Cell Therapy Global Market Report 2023" report has been added to  ResearchAndMarkets.com's offering.

This report provides strategists, marketers and senior management with the critical information they need to assess the market.

The global stem cell therapy market will grow from $5.14 billion in 2022 to $6.45 billion in 2023 at a compound annual growth rate (CAGR) of 25.5%. The stem cell therapy market is expected to grow to $11.88 billion in 2027 at a CAGR of 16.5%. 

Companies Mentioned

• Anterogen
• JCR Pharmaceuticals
• Medipost
• Osiris Therapeutics
• Pharmicell
• Astellas Pharma
• Cellectis
• Celyad
• Novadip Biosciences
• Gamida Cell
• Capricor Therapeutics
• Cellular Dynamics
• CESCA Therapeutics
• DiscGenics
• OxStem
• Mesoblast
• ReNeuron Group
• Takeda Pharmaceuticals
• Magellan
• Kolon TissueGene
• Stemedica Cell Technologies
• Holostem Terapie Avanzate S.r.l.
• NuVasive
• RTI Surgical
• AlloSource

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis

The stem cell therapy market includes revenues earned by entities by hematopoietic stem cells, skin stem cells, neural stem cells, and mesenchymal stem cells. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

Stem cell therapy refers to a form of regenerative medicine that uses stem cells or their by products to stimulate the body's natural repair process in damaged, malfunctioning, or wounded tissue. It is the next step in the transplantation of organs, replacing donor organs - which are scarce - with cells.

North America was the largest region in the stem cell therapy market in 2022. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the stem cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main types of stem cell therapy are allogeneic stem cell therapy and autologous stem cell therapy. Allogeneic stem cell transplantation involves transferring stem cells from a healthy person (the donor) to the patient's body after high-intensity chemotherapy or radiation, The various sources of the cells include adult stem cells; induced pluripotent stem cells, and embryonic stem cells that are used for the treatment of musculoskeletal disorders; wounds and injuries; cancer; autoimmune disorders and others. The therapies are used by hospitals and clinics.

The rising prevalence of chronic diseases contributed to the growth of the stem cell therapy market. Long working hours, limited physical activity, and unhealthy eating and drinking habits contribute to the prevalence of chronic diseases among people, thus driving the need for stem cell therapy. According to a United Nations article, by 2030, the proportion of global deaths due to chronic diseases is expected to increase to 70% of total deaths. The global burden of chronic diseases is expected to reach about 60%. The rising prevalence of chronic diseases is expected to drive the stem cell therapy market.

The high cost of stem cell therapy is expected to limit the growth of the stem cell therapy market. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding.

In less wealthy countries, the lack of cost-effective therapies for chronic diseases has impacted the health conditions of the population and has led to a low average life expectancy. According to the DVCSTEM, the average cost of stem cell therapy in the USA is between $20,000 to $25,000, in Mexico, it is $33,000, in Central America, it is $30,000, and in Asia, it is $50,000, thus restraining the growth of the market.

The companies in the stem cell therapy market are increasingly investing in strategic partnerships. A strategic partnership is a mutually beneficial agreement between two companies that do not compete directly with each other.

The countries covered in the stem cell therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Key Topics Covered:

1. Executive Summary

2. Stem Cell Therapy Market Characteristics

3. Stem Cell Therapy Market Trends And Strategies

4. Stem Cell Therapy Market - Macro Economic Scenario
4.1 COVID-19 Impact On Stem Cell Therapy Market
4.2 Ukraine-Russia War Impact On Stem Cell Therapy Market
4.3 Impact Of High Inflation On Stem Cell Therapy Market

5. Stem Cell Therapy Market Size And Growth
5.1. Global Stem Cell Therapy Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Stem Cell Therapy Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Stem Cell Therapy Market Segmentation
6.1. Global Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

• Allogeneic Stem Cell Therapy
• Autologous Stem Cell Therapy

6.2. Global Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

• Adult Stem Cells
• Induced Pluripotent Stem Cells
• Embryonic Stem Cells

6.3. Global Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

• Musculoskeletal Disorders
• Wounds and Injuries
• Cancer
• Autoimmune Disorders
• Other Applications

6.4. Global Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

• Hospitals

7. Stem Cell Therapy Market Regional And Country Analysis
7.1. Global Stem Cell Therapy Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Stem Cell Therapy Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

For more information about this report visit https://www.researchandmarkets.com/r/x0lt1y

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets